Nuclear Phosphoinositides on p53: A Novel Therapeutic Target for TNBC
Muhammad Salah
Advisor: Vincent Cryns, MD
Optimizing efficacy of standard-of-care anti-microtubule therapies
Caleb Carlsen
Advisor: Beth Weaver, PhD
6571 WIMR II
@ 3:30 pm - 4:30 pm
Nuclear Phosphoinositides on p53: A Novel Therapeutic Target for TNBC
Muhammad Salah
Advisor: Vincent Cryns, MD
Optimizing efficacy of standard-of-care anti-microtubule therapies
Caleb Carlsen
Advisor: Beth Weaver, PhD